pbyi: the cashflow

MyFinsight

For the quarter ending 2025-09-30.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Cash Flow	2025-09-30	2025-06-30
Net decrease in cash, cash equivalents and restricted cash	-15,694	-14,557
Cash and cash equivalents at beginning of period	71,310	-
Cash and cash equivalents at end of period	55,616	-

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

For the quarter ending 2025-09-30.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Cash Flow	2025-09-30	2025-06-30
Net decrease in cash, cash equivalents and restricted cash	-15,694	-14,557
Cash and cash equivalents at beginning of period	71,310	-
Cash and cash equivalents at end of period	55,616	-

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

PUMA BIOTECHNOLOGY, INC. (PBYI)